Key points are not available for this paper at this time.
1 Including those whose primary purpose is directed towards patients and that entail both patients and therapists. 2 European countries are currently working out own regulatory frameworks, the European Medicines Agency has not yet designed a regulatory pathway for evaluation and reimbursement of DTx. 3 Denmark and other Nordic countries are taking a coordinated approach by stepwise integrating other main aspects of health care digitalization like electronic health records and platforms implementing mobile apps along the process (Nordic Innovation 2018).
Fürstenau et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: